dapa-ckd: renal benefits of sglt2 inhibition in people with and without diabetes | hiddo heerspink
Published 3 years ago • 7.2K plays • Length 8:14Download video MP4
Download video MP3
Similar videos
-
6:11
dapa-ckd: does confirmed renoprotection make the case for first-line sglt2 inhibition? | luigi gnudi
-
9:06
sglt2 inhibitors in chronic kidney disease
-
16:24
how sglt2 inhibitors protect the kidney
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
10:55
what are sglt2 inhibitors and how do they affect kidney disease?
-
6:01
tahap-tahap penyakit buah pinggang kronik (chronic kidney disease ckd)
-
25:43
kencing manis dan penyakit kronik (part 1)
-
6:09
how diabetes destroys the human body
-
5:08
nephroworldcup 2022: metformin or sglt2i in ckd patients with diabetes
-
2:56
sglt2i or finerenone with raas inhibitors benefits ckd diabetics' kidneys, study finds
-
2:58
diabetic kidney disease, animation
-
1:01:33
hiddo lambers heerspink, phd - sglt2 inhibitors: extending organ protection diabetes to non-diabetes
-
3:32
sglt-2 in cardiovascular and kidney outcomes declare timi 58
-
2:12
dapa-ckd discussion - manesh patel, md
-
2:03
dapagliflozin clinically and cost effective in patients with chronic kidney disease dapa ckd trial
-
56:07
chronic kidney disease and diabetes
-
8:40
chronic kidney disease - causes, symptoms, diagnosis, treatment, pathology
-
7:38
dapa ckd
-
32:00
role of sglt2 inhibitors in ckd
-
1:25:05
chronic kidney disease (ckd) | etiology, pathophysiology, clinical features, diagnosis, treatment
-
1:00:55
sglt2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney disease
-
9:22
dr. scott solomon: dapagliflozin benefits patients with heart failure and kidney disease